Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries
- 8 December 2020
- journal article
- other
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 19 (4) , 419-441
Abstract
Respiratory syncytial virus (RSV) causes approximately 120,000 deaths annually in children <5 years, with 99% of fatalities occurring in low- and middle-income countries (LMICs). There are numerous...Keywords
This publication has 242 references indexed in Scilit:
- Association of RSV-related hospitalization and non-compliance with Palivizumab among commercially insured infants: a retrospective claims analysisBMC Infectious Diseases, 2013
- Respiratory viral pathogens associated with lower respiratory tract disease among young children in the highlands of Papua New GuineaJournal of Clinical Virology, 2012
- A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)European Journal of Clinical Microbiology & Infectious Diseases, 2012
- Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populationsEuropean Journal of Pediatrics, 2011
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virusProceedings of the National Academy of Sciences of the United States of America, 2010
- Incubation periods of acute respiratory viral infections: a systematic reviewThe Lancet Infectious Diseases, 2009
- The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccinesVaccine, 2007
- Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemicsEuropean Journal of Pediatrics, 2007
- Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, SpainEpidemiology and Infection, 2005